Fentonium bromide

Pharmaceutical drug

A03BB04 (WHO)

Pharmacokinetic dataBioavailability1Identifiers

IUPAC name

[8-Methyl-8-[2-oxo-2-(4-phenylphenyl)ethyl]-8-azoniabicyclo[3.2.1]octan-3-yl] 3-hydroxy-2-phenylpropanoate bromide

CAS Number

5868-06-4^Y

PubChem CID

71534

DrugBank

DB08978^N

UNII

XS152O7VCZ

ECHA InfoCard100.025.018

Chemical and physical dataFormulaC₃₁H₃₄BrNO₄Molar mass564.520 g·mol⁻¹ ^NY (what is this?) (verify)

Fentonium bromide (INN) is an anticholinergic and antispasmodic atropine derivative.^[1] In the US its patent number is 3,356,682.^[2] It is sold by Sanofi-Aventis and Zambon.^[3]

References

^ Milne GW (2002). "Fentonium bromide". Drugs: Synonyms and Properties (2nd ed.). Aldershot, Hampshire, England: Ashgate. p. 2785. ISBN 978-0-566-08491-1.
^ "Fentonium". DrugBank. 17 August 2016. Retrieved 19 December 2016.
^ "Ulcesium (fentonium bromide) drug & pharmaceuticals. Ulcesium available forms, doses, prices". sdrugs.com. Retrieved 19 December 2016.

Drugs for functional gastrointestinal disorders (A03)

Drugs for
functional
bowel
disorders

Antimuscarinics

Tertiary amino group	Oxyphencyclimine Camylofin Mebeverine Trimebutine Rociverine Dicycloverine Dihexyverine Difemerine Piperidolate
Quaternary ammonium compounds	Benzilone Mepenzolate Pipenzolate Glycopyrronium Oxyphenonium Penthienate Methantheline Propantheline Otilonium Tridihexethyl Isopropamide Hexocyclium Poldine Bevonium Diphemanil Tiemonium Prifinium Timepidium Fenpiverinium